Evidence map›Paper›PMID 40401879›Full record

ArticleDermatology practical & conceptual2025

Dermoscopic Features of Eccrine Poromas in Diverse Skin Phototypes: A Retrospective Study of 26 Cases.

Bengu Nisa Akay, Handan Merve Erol Mart, Aylin Okcu Heper

Abstract read
In one paragraph

Article in Dermatology practical & conceptual, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bengu Nisa AkayDepartment of Dermatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Handan Merve Erol MartDepartment of Dermatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Aylin Okcu HeperDepartment of Pathology, Faculty of Medicine, Ankara University, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEccrine poroma (EP) is a benign adnexal tumor. Establishing a definitive diagnosis based on clinical and dermoscopic findings can be challenging.

objectivesThe aim of this study was to perform a comprehensive analysis of the dermoscopic features of pigmented, hypopigmented, and nonpigmented variants of EP and to compare these dermoscopic features in patients with dark and light Fitzpatrick skin phototypes.

methodsA total of 26 cases of histopathologically confirmed EP were included. Each case was categorized as pigmented, hypopigmented, or nonpigmented based on the melanin content within the lesion. Patients were classified according to their Fitzpatrick skin phototypes. Dermoscopic images were subjected to revised pattern analysis, and the results were compared with the existing literature.

resultsRegarding Fitzpatrick skin phototype, four (15.4%), 11 (42.3%), six (23.1%), and five (19.2%) patients had Fitzpatrick skin phototypes II, III, IV, and V, respectively. Of the cases, 17 (65.4%) were classified as nonpigmented, three (11.5%) as hypopigmented, and six (23.1%) as pigmented EP. All pigmented EP cases occurred in patients with dark skin and were located on non-acral sites. Polymorphic vascular pattern, branched vessels with rounded endings, linear-irregular vessels, interlacing white areas around vessels, and collarettes were more frequently observed in patients with light skin. In contrast, clod vessels, coiled vessels, white lines, ulceration, fiber sign, scales, and structureless areas were more common in patients with dark skin.

conclusionsThis study underscores the significant dermoscopic diversity observed in EP, revealing distinct patterns based on pigmentation and Fitzpatrick skin phototypes.

Identifiers

PMID40401879
PMCPMC12090919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.